Israeli startup Intensix is trialing an Intensive Care Unit patient monitoring system, which gives an early warning of impending sepsis and organ failure that kills 30% of ICU patients, and scientists at Israel’s Technion have discovered how to use proteins to suppress unwanted gene activity.